NCT05450055Not yet recruiting
Intraperitoneal Lidocaine in Ovarian Cancer Surgery
A Randomized Controlled Trial to Investigate Effect of Postoperative Intraperitoneal Lidocaine on the Analgesic and Prognosis of Patients With Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 13 Jul 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main objective of this trial is to improve the postoperative analgesia effect and prognosis of patients with ovarian cancer after laparotomy surgery. This is a randomized, double-blind, controlled trial to evaluate analgesia and patient outcomes after local peritoneal anesthesia after surgery.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 31 May 2022
- Start date
- 18 Jul 2022
- Primary completion date
- 30 Jul 2024
- Lead sponsor
- Peking University Third Hospital
- Diseases
- Ovarian cancer
- NCT number
- NCT05450055
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 18 Jul 2022 to the primary completion date, 30 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severe liver and kidney dysfunction existed before surgery
Other illness
- Suffering from mental illness or unable to cooperate with pain and related index scoring, unable to use automatic pump.
- Peritoneal infection existed before surgery
- Past history of arrhythmia
- Known allergy to local anesthetics
Other
- Do not agree to participate in the research
Who the study is looking for
- The American Society of Anesthesiologists (ASA) rated them as grade I to II, aged 18 to 75 years.
- Patients undergoing elective laparotomy for ovarian cancer reduction (surgical resection includes the whole uterus with or without double adnexa, lymph node biopsy, dissection, appendectomy, etc.).
Age in the registry: 18 years to 75 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University Third Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.